Molecular diagnostics of acute intermittent porphyria

References

• Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: The Metabolic and Molecular Basis of Inherited Disease. Scriver CR, Beaudet A, Sly WS, Valle D (Eds), McGraw-Hill, NY, USA, 2991–3062 (2001).
   Google Scholar
• Meyer UA, Strand L,J, Doss M, Rees AC, Marver HS. Intermittent acute porphyria — demonstration of a genetic defect in porphobilinogen metabolism. N. Engl. Med 286, 1277–1282 (1972). 22Jover R, Hoffmann F, Scheffler-Koch V.
   Google Scholar
• Grandchamp B, Picat C, Kauppinen R etal Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase. Eur. Clin. Invest. 19,415–148 (1989).
   PubMedGoogle Scholar
• Poh-Fitzpatrick MB. A plasma porphyrin fluorescence marker for variegate porphyria. Arch. Delmar& 116,543–547 (1980).
   Google Scholar
• Kauppinen R, von und zu Fraunberg M. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. Clin. Chem. 48,1891-1900 (2002).
   Google Scholar
• •Large series of acute intermittent porphyria (AIM patients analyzed biochemically and using mutation analysis.
   Google Scholar
• Andersson C, Thunell S, Floderus Y eta]. Diagnosis of acute intermittent porphyria in Northern Sweden: an evaluation of mutation analysis and biochemical methods. j Int. Med 237,301–308 (1995).
   Google Scholar
• Goldberg A. Acute intermittent porphyria: a study of 50 cases. Q. Med 28,183–209 (1959).
   Google Scholar
• Stein JA, Tschudy DR Acute intermittent porphyria: a clinical and biochemical study of 46 patients. Medicine 49,1–16 (1970).
   PubMed Web of Science ®Google Scholar
• Mustajoki P, Koskelo R Hereditary hepatic porphyrias in Finland. Acta Med Scand 200,171–178 (1976).
   PubMedGoogle Scholar
• Crimlisk HL. The little imitator: porphyria: a neuropsychiatric disorder. .1. Neural Neumsurg. fiychiatry62, 319–328 (1997).
   Google Scholar
• ••Good clinical review.
   Google Scholar
• Kauppinen R, Mustajoki R Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors and associated diseases. Medicine 71,1–13 (1992).
   PubMed Web of Science ®Google Scholar
• •One of the few current clinical articles on AIP.
   Google Scholar
• Meyer UA, Schuurmans MM, Lindberg RL. Acute porphyrias: pathogenesis of neurological manifestations. Semin. Liver Dis. 18, 43–52 (1998).
   Google Scholar
• •Good description of potential pathophysiology of AIP.
   Google Scholar
• Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attacks. Arch. Int. Med
   Google Scholar
• ,2004-2008 (1993).
   Google Scholar
• •Well-documented series of AIP patients treated with heme arginate.
   Google Scholar
• Jeans JB, Savik K, Gross CR eta]. Mortality in patients with acute intermittent porphyria requiring hospitalization: a United States case series. AinJ Med Genet. 65,269–273 (1996).
   PubMed Web of Science ®Google Scholar
• Andersson C, Lithner Hypertension and renal disease in patients with acute intermittent porphyria. j Intern. Med 236,169–175 (1994).
   PubMed Web of Science ®Google Scholar
• Andersson C, Bjersing L, Lithner The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. j Intern. Med 240, 195–201 (1996).
   PubMed Web of Science ®Google Scholar
• Bradbury M. The Concept of a Blood—Brain Barrier. John Wiley & Sons Ltd., Chichester, UK (1979).
   Google Scholar
• Yen PS, Chen CJ, Lui CC, Wai YY, Wan YL. Diffusion-weighted magnetic resonance imaging of porphyric encephalopathy: a case report. Eur. Neural 48,119–121 (2002).
   Google Scholar
• Bonkowsky HL, Barnard GE Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology. Semin. Liver Dir. 18,57–65 (1998).
   PubMedGoogle Scholar
• Schirmer M, Calamia KT, Wenger M, Klauser A, Salvarani C, Moncayo R. 18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective. Exp. Gerontal 38,463–470 (2003).
   Google Scholar
• Heils A, Mossner R, Lesch K. The human serotonin transporter gene polymorphism: basic research and clinical implications. j Neural Tatum. 104, 1005–1014 (1997).
   PubMed Web of Science ®Google Scholar
• Lindberg RL, Martini R, Baumgatner M eta]. Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria. j Clin. Invest. 103, 1127–1134 (1999).
   Google Scholar
• Beukeveld GJ, Wolthers BG, Nordmann Y, Deybach JC, Grandchamp B, Wadman SK. A retrospective study of a patient with homozygous form of acute intermittent porphyria. .1. Inherit. Metab. Dis. 13, 673–683 (1990).
   Google Scholar
• Halapi E, Hakonarson H. Advances in development of genetic markers for the diagnosis of disease and drug response. Expert Rev Mal Diagn. 2,411–21 (2002).
   PubMedGoogle Scholar
• Mustajoki P, Mustajoki S, Rautio A, Arvela P, Pelkonen 0. Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and healthy men. Clin. Pharmacol Ther 56,9–13 (1994).
   Google Scholar
• Namba H, Narahara K, Tsuji K, Yokoyama Y, Seino Y. Assignment of human porphobilinogen deaminase to 11q24.1-q24.2 by in situ hybridization and gene dosage studies. Cytogenet. Cell Genet. 57,105-108 (1991).
   Google Scholar
• Raich N, Romeo PH, Dubart A, Beaupain D, Cohen-Solal M, Goosens M. Molecular cloning and complete primary sequence of human erythrocyte PBG deaminase. Nucleic Acids Res. 14, 5955–5968 (1986).
   Google Scholar
• ••First article related to the characterizationof the porphobilinogen deaminase (PBGD) cDNA.
   Google Scholar
• Yoo HW, Warner CA, Chen CH, Desnick RJ. Hydroxymethylbilane synthase: complete genomic sequence and amplifiable polymorphisms in the human gene. Genomics 15,21–29 (1993).
   PubMed Web of Science ®Google Scholar
• Grandchamp B, de Verneuil H, Beaumont C, Chretien S, Walter 0, Nordmann Y. Tissue-specific expression of porphobilinogen deaminase: two isoenzymes from a single gene. Eur. Biochem. 162,105-110 (1987).
   Google Scholar
• ••First article describing tissue specificityof PBGD.
   Google Scholar
• Gubin AN, Miller JL. Human erythroid porphobilinogen deaminase exists in two splice variants. Blood 97,815–817 (2002).
   Google Scholar
• Tschudy DP, Valsamis M, Magnussen CR. Acute intermittent porphyria: clinical and selected research aspects. Ann. Int. Med 83, 851–864 (1975). Mustajoki P, Kauppinen R, Lannfelt L, Lilius L, Koistinen J. Frequency of low erythrocyte porphobilinogen deaminase activity in Finland. J: int. Med. 231, 389–395 (1992).
   Google Scholar
• Nordmann Y, Puy H, Da Silva V etal Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. Int. Med 242,213–217 (1997).
   Google Scholar
• Andersson C. Acute Intermittent Porphyria in Northern Sweden. A Population-Based Study Departments of Family Medicine and Medicine, University of Umea, Sweden, 102 (1997).
   Google Scholar
• Schneider-Yin X, Hergersberg M, Goldgar DE eta]. Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients. Hum. Hered. 54,69-81 (2002).
   Google Scholar
• De Siervi A, Rossetti MV, Parera VE et al Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation. Am. j Merl Genet. 86,366-375 (1999).
   Google Scholar
• Mullis KB, Faloona E Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. In: Methods in Enzymology Wu R (Ed.), Academic Press, NY, USA, 335–350 (1987).
   Google Scholar
• Saiki RK, Scharf S, Faloona F etal Enzymatic amplification of P-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 20,1350–1354 (1985).
   Google Scholar
• Minarik M, Minarikova L, Bjorheim J, Ekstrom PO. Cycling gradient capillary electrophoresis: a low-cost tool for high-throughput analysis of genetic variations. Electrophoresis 24,1716–1722 (2003).
   PubMedGoogle Scholar
• Kauppinen R, Mustajoki S, Pihlaja H, Peltonen L, Mustajoki P. Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene. Hum. Mal Genet. 4,215-222 (1995).
   Google Scholar
• Schreiber WE, Rozon C, Fong F, Jama A. Detection of polymorphisms and mutations in the porphobilinogen deaminase gene by nonisotopic SSCR Clin. Chem. 40,1982–1983 (1994).
   Google Scholar
• Nissen H, Petersen NE, Mustajoki S etal Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis. Hum. Mutat. 9,122–130 (1997).
   PubMed Web of Science ®Google Scholar
• Ong PM, Lanyon WG, Hift RJ eta]. Identification of two novel mutations in the hydroxymethylbilane synthase gene in three patients from two unrelated families with acute intermittent porphyria. Hum. Hemd. 48,24–29 (1998).
   Google Scholar
• Schreiber WE, Fong F, Nassar BA, Jamani A. Heteroduplex analysis detects frameshift and point mutations in patients with acute intermittent porphyria. Hum. Genet. 92,161–166 (1995).
   Google Scholar
• Tchernitchko D, Lamoril J, Puy H etal Evaluation of mutation screening by heteroduplex analysis in acute intermittent porphyria: comparison with denaturing gradient gel electrophoresis. Clin. Chim. Acta 279,133–143 (1999).
   PubMedGoogle Scholar
• Fischer J, Schwab M, Eichelbaum M, Zanger UM. Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatography. Genet. Test. 7, 97–105 (2003).
   PubMedGoogle Scholar
• Lam CW, Poon PM, Tong SF etal. Novel mutation and polymorphisms of the HMBS gene detected by denaturing HPLC. Clin. Chem. 47,343–346 (2001).
   Google Scholar
• Mustajoki S, Kauppinen R, Mustajoki P, Suomalainen A, Peltonen L. Steady-state transcript levels of the porphobilinogen deaminase gene in patients with acute intermittent porphyria. Genome Res. 7, 1054–1060 (1997).
   Google Scholar
• Landers JR Molecular diagnostics on electrophoretic microchips. Ann. Chem. 75, 2919–2927 (2003).
   Google Scholar
• Bonk T, Humeny A, Gebert J, Sutter C, von Knebel Doeberitz M, Becker CM. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based detection of microsatellite instabilities in coding DNA sequences: a novel approach to identify DNA-mismatch repair-deficient cancer cells. Clin. Chem. 49,552-561 (2003).
   Google Scholar
• Law WK, Choy KW, Lam CW. Novel single nucleotide polymorphism (9678G->A) for linkage analysis of acute intermittent porphyria. Clin. Chem. 45, 308–309 (1999).
   Google Scholar
• Mauzerall D, Granick S. The occurrence and determination of 8-aminolevulinic acid and porphobilinogen in urine. J. Biol. Chem. 219,435-436 (1956).
   Google Scholar
• Lim CK, Peters TJ. Urine and fecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Clin. Chim. Acta 139,55–63 (1984).
   PubMed Web of Science ®Google Scholar
• Andersson C, Floderus Y, Wikberg A, Lithner E The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study. Scam/. j Clin. Lab. Invest. 60,643-648 (2000).
   Google Scholar